Workflow
Drug Testing
icon
Search documents
Intelligent Bio Solutions Accelerates Global Growth with SmarTest® Patch Agreement, Reinforces U.S. Expansion Path as FDA Approval Remains a Strategic Priority
Globenewswire· 2025-07-16 12:30
Company Overview - Intelligent Bio Solutions Inc. (INBS) is a medical technology company focused on delivering intelligent, rapid, non-invasive testing solutions [6] - The company aims to revolutionize portable testing through its Intelligent Fingerprinting Drug Screening System, which analyzes fingerprint sweat for drug use [6] Partnership and Product Expansion - INBS announced a global distribution agreement with SMARTOX® to introduce the SmarTest Patch drug detection product to international markets outside the U.S. and Canada [1][2] - The SmarTest Patch enhances INBS's product portfolio by providing continuous sweat-based drug detection over an extended period, targeting sectors such as justice and rehabilitation [2][3] Market Potential - The global drug testing market is projected to grow significantly, reaching approximately $18.6 billion by 2030, presenting new opportunities for INBS [2] - The partnership with SMARTOX supports INBS's international growth strategy and introduces an additional revenue stream aligned with its broader expansion goals [2] Regulatory Strategy - INBS is prioritizing securing FDA clearance for its fingerprint sweat-based drug testing technology for use beyond forensic settings as part of its U.S. expansion strategy [4] - The company is actively engaging with regulatory consultants and stakeholders to bring its innovative solution to market in the U.S. [4] Current Operations - INBS currently serves over 450 active accounts in 24 countries, providing non-invasive drug testing solutions across health, justice, and workplace sectors [3]
Intelligent Bio Solutions and Spjotgard Drive Rapid Adoption of Fingerprint Drug Testing Across Scandinavia
Globenewswire· 2025-06-25 12:30
Core Insights - Intelligent Bio Solutions Inc. (INBS) is advancing drug screening technology through its partnership with Spjotgard, enhancing the adoption of its Intelligent Fingerprinting Drug Screening System in Scandinavia [1][6] - Spjotgard, established in 2021, has positioned INBS' technology as a leading solution in response to the demand for modern drug testing methods [2][7] - The fingerprint drug testing system is gaining traction due to its non-invasive nature, quick results, and suitability for various sectors including logistics, construction, and education [3][5][10] Company Overview - Intelligent Bio Solutions Inc. specializes in non-invasive drug testing solutions, with a focus on fingerprint sweat analysis for rapid results [10] - The company has over 450 accounts across 24 countries, indicating a strong market presence and ongoing evolution in drug screening technology [6] - INBS' Drug Screening System is designed to be hygienic and cost-effective, screening for commonly used drugs in workplace settings [10] Market Dynamics - There is a growing interest in fingerprint-based testing in Scandinavia, driven by the need for more hygienic and less invasive drug testing alternatives [3][5] - Spjotgard is expanding its market presence through collaborations with drug-detection service providers and is actively targeting Norway for future growth [4][5] - The Scandinavian region, particularly Sweden, is recognized for its progressive drug testing policies, setting a standard for neighboring countries [5]
Psychemedics Releases 2025 Workforce Insights Report
Globenewswire· 2025-06-16 13:00
Core Insights - The 2025 Psychemedics Workforce Insights Report highlights the evolving drug landscape and its implications for workplace safety, hiring practices, and employer risk [2][3] - Employers face increasing pressure to maintain safe and compliant workplaces due to new synthetic substances, rising marijuana potency, and changing laws [3] Industry Trends - The report analyzes data from hundreds of thousands of hair drug testing samples collected in 2024 across various sectors, including transportation, manufacturing, healthcare, and government [2] - Positive drug test rates in the healthcare and manufacturing industries reached 14.7% and 14.6%, indicating a significant risk in these sectors [6] Emerging Threats - Synthetic opioids, particularly fentanyl and ultra-potent nitazenes, are on the rise, with some nitazenes being up to 20 times stronger than fentanyl [6] - There is a notable resurgence in cocaine and methamphetamine use, especially in high-pressure industries [6] - Legalization of marijuana has led to a 10% increase in workplace injuries among young workers in states with legalized recreational cannabis [6] Recommendations for Employers - The report emphasizes the need for comprehensive drug testing strategies that include education, prevention, and support, beyond mere detection [4] - Hair testing is highlighted as the most reliable method for drug detection, offering a 90-day detection window and high resistance to evasion [6]
Intelligent Bio Solutions Expands U.S. Forensic Market Presence, Seeks FDA Clearance for Breakthrough Fingerprint Drug Testing
Globenewswire· 2025-06-11 12:30
Core Insights - Intelligent Bio Solutions Inc. (INBS) is expanding its presence in the U.S. Forensic Use Only Market through a partnership with SMARTOX, having deployed over 50 Intelligent Fingerprinting Drug Screening Readers and conducted over 7,000 screening tests, including more than 1,500 in 2024 [1][2][3] Company Overview - INBS specializes in intelligent, rapid, non-invasive testing solutions, particularly in drug screening technology that reduces reliance on invasive methods [2][7] - SMARTOX, founded in 2012, provides drug and alcohol testing products and services across various sectors, including healthcare and criminal justice, and is committed to innovation and customer service [6] Market Demand and Technology - There is an accelerated demand for non-invasive, rapid testing in forensic settings, with INBS's technology credited for improving efficiency and user dignity while simplifying operations [2][5] - The Intelligent Fingerprinting Drug Screening System allows for hygienic, non-invasive drug screening in under ten minutes using fingerprint sweat, which is beneficial for safety-critical industries [4][7] Regulatory Efforts - INBS is actively pursuing FDA clearance for its opiate test system for codeine, aiming for broader market expansion in 2025, including workplace drug testing [3][4]
Omega Laboratories Delivers Marijuana Breath Test Validation Packet to Cannabix Technologies Inc. - Completing Major Milestone under Strategic Partnership
Globenewswire· 2025-06-05 12:45
Core Insights - Cannabix Technologies Inc. has achieved a significant milestone by receiving a Validation Packet from Omega Laboratories for its Marijuana Breath Test (MBT) technology, which tests for delta-9 THC in breath samples [1][2] - The validation process confirms the capability to simultaneously quantify Δ-9-THC, Δ-8-THC, CBD, and CBN in breath aerosols, establishing Cannabix and Omega as leaders in breath testing for recent marijuana use [2][3] - The strategic partnership between Cannabix and Omega includes plans for commercialization, marketing, and distribution of the MBT, with Omega integrating Cannabix's Breath Cartridges into its services [3][4] Company Overview - Cannabix Technologies Inc. specializes in developing breath testing technologies for marijuana and alcohol, focusing on detecting recent use of delta-9 THC [7] - Omega Laboratories, based in Ohio, has over 24 years of experience in drug testing and offers advanced testing solutions to over 6,000 clients globally [5][6] - The partnership allows Omega to appoint a board member from its side, reflecting a collaborative approach to advancing the MBT technology [4]
Intelligent Bio Solutions to Showcase Fingerprint Drug Testing at RISE25 Conference from May 28-31, Supporting Innovation in U.S. Forensic Drug Testing
Globenewswire· 2025-05-22 12:30
Core Insights - Intelligent Bio Solutions Inc. (INBS) will participate in the RISE25 conference, focusing on addiction, mental health, and justice innovation, which attracts over 7,000 attendees annually [1][3] - The company aims to showcase its Intelligent Fingerprinting Drug Testing Solution, which is currently utilized in the U.S. for forensic purposes through its partnership with SMARTOX [1][2] Company Overview - INBS is a medical technology company specializing in rapid, non-invasive testing solutions, with over 450 active accounts across 24 countries [1][4] - The Intelligent Fingerprinting Drug Screening System detects recent drug use through fingerprint sweat, providing results in under ten minutes, making it suitable for treatment courts and probation programs [2][6] Market Context - RISE25 serves as a national platform for professionals in public health and justice, focusing on evidence-based approaches for individuals affected by substance use and mental health issues [3][4] - The U.S. market for forensic use of drug testing presents significant expansion opportunities for INBS, which believes its technology can deliver substantial benefits in this sector [4] Strategic Partnerships - INBS collaborates with SMARTOX, a U.S.-based provider of drug and alcohol testing products, to enhance its market presence and support innovative solutions in various sectors [5][6] - The partnership aims to address the growing demand for reliable on-site drug testing solutions across workplaces, treatment facilities, and the justice system [1][4]
Psychemedics Named “Most Innovative Drug Testing Company of the Year”
GlobeNewswire News Room· 2025-05-16 13:00
Core Insights - Psychemedics Corporation has been recognized as the "Most Innovative Drug Testing Company of the Year" by Acquisition International Magazine in the 2025 Global Excellence Awards [1][2] - The recognition highlights Psychemedics' leadership in drug detection science, particularly with the launch of Enhanced Quartile Reporting, which offers deeper insights into drug use severity and behavioral risk patterns [2][3] Company Innovations - Enhanced Quartile Reporting provides interpretive value by categorizing positive results into population-based quartiles, aiding employers in high-risk industries to make informed safety and risk management decisions [3][4] - The company emphasizes its commitment to innovation, focusing on improving testing reliability and providing actionable insights for better hiring and risk decisions [3][4] Technology and Market Position - Psychemedics' hair testing technology is noted for its unmatched detection sensitivity, tamper resistance, and extended detection window, making it a trusted solution for various sectors including Fortune 500 companies, law enforcement, schools, and insurers [4][6] - The company is dedicated to maintaining high standards in substance abuse testing and providing valuable insights to its clients [6]
Intelligent Bio Solutions Accelerates Global Adoption of Fingerprint Drug Testing
Globenewswire· 2025-05-15 13:00
Core Insights - Intelligent Bio Solutions Inc. has surpassed 450 active accounts across 24 countries, driven by global demand for its fingerprint drug testing solutions [1][2][5] - The company added 35 new accounts in fiscal Q3, highlighting the growing adoption of its Intelligent Fingerprinting Drug Screening System, which provides results in under ten minutes [2][5] - The company is expanding into various sectors, including luxury marine, waste and recycling in Australia, and retail, indicating a strategic focus on high-demand markets [3][8] Company Growth and Expansion - Recent commercial milestones include entry into the luxury marine sector in Europe and expansion into regional testing programs in Australia [3] - The distributor network has grown to 19 countries through 18 partners, enhancing localized support and market access [4] - The company aims to strengthen its position in safety-critical industries, with plans for entry into the multi-billion-dollar U.S. market [5][6] Product and Technology - The Intelligent Fingerprinting Drug Screening System is designed for rapid, non-invasive testing, screening for drugs commonly found in the workplace [6] - The technology allows for sample collection in seconds and delivers results in under ten minutes, making it a valuable tool for employers [6] - The system's portability and ease of use are key factors driving its adoption across various industries [2][5]
Intelligent Bio Solutions Expands Middle East Market Reach with Arabic Integration in Drug Screening System
GlobeNewswire News Room· 2025-03-31 12:30
Core Viewpoint - Intelligent Bio Solutions Inc. has integrated Arabic as the second international language into its Intelligent Fingerprinting Drug Screening System, enhancing accessibility for Arabic-speaking organizations and reinforcing its presence in the Middle East [1][2][4]. Company Developments - The integration of Arabic follows the company's expansion plans in the Middle East through a partnership with Ivy Diagnostics, targeting a market where Arabic is spoken by approximately 450 million people [2][4]. - The addition of Arabic is expected to improve usability for organizations in safety-critical industries, law enforcement, and drug rehabilitation, aligning with the growing global demand for innovative drug testing solutions [2][3]. Market Potential - The workplace drug testing market in Saudi Arabia is projected to reach $64.5 million by 2030, indicating significant growth opportunities for the company in the region [3]. - The integration of Arabic will facilitate the incorporation of the company's technology into existing safety protocols, enhancing workplace safety standards [3]. Strategic Growth - The integration of Arabic is a key milestone in the company's broader international growth strategy, which includes scaling operations across North and South America, Europe, Asia Pacific, and the Middle East [4]. - The company aims to expand its presence in 19 countries and has made strategic milestones, including a recent FDA 510(k) submission and plans to enter the multi-billion dollar U.S. market in 2025 [4].
Psychemedics Launches Groundbreaking Quartile Reporting for Enhanced Drug Testing Insights
Globenewswire· 2025-03-03 14:00
Core Insights - Psychemedics Corporation has launched an innovative Quartile Reporting feature for hair drug testing, providing organizations with enhanced insights into drug test results and promoting safer workplaces [1][3][4] Product Features - The Quartile Reporting feature segments test results into four quartiles: Lower, Median, Upper, and Highest, allowing clients to benchmark substance use trends within their workforce [2][3] - This feature is available to all Psychemedics clients at no additional cost, reflecting the company's commitment to delivering exceptional value [4] Company Mission and Commitment - The company aims to provide reliable and actionable drug testing solutions, enhancing clarity and precision in understanding drug test results [3] - Psychemedics is dedicated to innovation and meeting the growing demand for comprehensive drug testing data, positioning itself as a leader in the evolving drug testing landscape [3][4] Benefits of Quartile Reporting - Enhanced insights allow organizations to understand individual results in the context of other positive reports, aiding in data-driven decision-making [5] - Real-time analytics provide up-to-date data and trends, empowering clients to act confidently in their hiring, retention, and compliance strategies [5]